Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Glioblastoma × Biopsy × Clear all

Phase

Status

Recruiting 2 Completed 2 Active not recruiting 2 Withdrawn 1 Terminated 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 8 Melanoma 6 Squamous Cell Carcinoma of Head and Neck 4 Prostatic Neoplasms 4 Neoplasm Metastasis 4 Multiple Myeloma 4 Mouth Neoplasms 4 Colorectal Neoplasms 4 Uterine Cervical Neoplasms 3 Triple Negative Breast Neoplasms 3 Rectal Neoplasms 3 Neoplasms 3 Head and Neck Neoplasms 3 Uterine Cervical Dysplasia 2 Skin Neoplasms 2 Sarcoma, Kaposi 2 Sarcoma 2 Oropharyngeal Neoplasms 2 Lymphoma, Large B-Cell, Diffuse 2 Lymphoma, Follicular 2 Inflammatory Breast Neoplasms 2 HIV Infections 2 Colonic Neoplasms 2 Uveal Melanoma 1 Urinary Bladder Neoplasms 1 Urinary Bladder Diseases 1 Unspecified Adult Solid Tumor, Protocol Specific 1 Turcot syndrome 1 Thrombocytosis 1 Squamous Intraepithelial Lesions 1

Interventions

Temozolomide 49 Radiotherapy 22 Bevacizumab 22 Radiation 10 Carmustine 6 Radiosurgery 5 Magnetic Resonance Spectroscopy 5 Lomustine 5 Irinotecan 5 Radiotherapy, Intensity-Modulated 4 Nivolumab 4 Erlotinib Hydrochloride 4 Cilengitide 4 Aminolevulinic Acid 4 vocimagene amiretrorepvec 3 vitespin 3 sargramostim 3 poly ICLC 3 pembrolizumab 3 fluoromisonidazole 3 carmustine, poliferprosan 20 drug combination 3 TPI-287 3 O(6)-benzylguanine 3 Ipilimumab 3 Granulocyte-Macrophage Colony-Stimulating Factor 3 Flucytosine 3 Dynamic Contrast Enhanced Magnetic Resonance Imaging 3 2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide 3 spartalizumab 2 selinexor 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02062372 2018-08-17

Spatial Analysis and Validation of Glioblastoma on 7 T MRI

Maastricht Radiation Oncology

Phase NA Terminated

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡